Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-18
2007-09-18
McKane, Joseph K. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10524993
ABSTRACT:
Pharmaceutically suitable crystalline and amorphous alkali and earth-alkali salts of 2-n-butyl-4-chloro-5-hidrox-ymethyl-1-[[2′-(1 H-tetrazole-5-yl)[1.1′-biphenyl]-4-yl]-1 Himidazole have been prepared and new manufacturing, purification and isolation procedure for said salts in high purity have been described. Stable pharmaceutical compositions containing new crystalline potassium salts of 2-n-butyl-5-chloro-5hidroxymethyl-1-[[2′-(1H-tetrazole-5-yl)[1.1′-biphenyl]-44-yl]-1H-imidazole have been prepared.
REFERENCES:
patent: 5795904 (1998-08-01), Cohen
patent: 5962500 (1999-10-01), Eide et al.
patent: 2004/0097568 (2004-05-01), Reddy et al.
Brittain in Polymorphism in Pharmacetical Solids (1999).
Elbary et al., “Polymorphic Transformation of Losartan”, Egypt. J. Pharm. Sci., vol. 40, No. 1, pp. 49-59 (1999).
Antoncic Ljubomir
Copar Anton
Ham Zoran
Husu-Kovacevic Breda
Marolt Boris
Freistein Andrew B.
Lek Pharmaceuticals D.D.
McKane Joseph K.
Thallemer John D.
LandOfFree
Preparation of new pharmaceutically suitable salt of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of new pharmaceutically suitable salt of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of new pharmaceutically suitable salt of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3748333